Medi-Globe Group

Medi-Globe is also engaged in developing new medical devices and products within the fields of gastroenterology, vascular cardiology, urology and related fields, of which the first to be commercialized is the GLYCOcell line of wound care products.

The Medi-Globe Group of companies is comprised of several smaller subsidiaries combined to create a highly vertically integrated entity. The company possesses the ability to develop product concepts into finished, market-ready products, and to even accommodate sales and distribution in various countries throughout the world. Medi-Globe maintains one large-scale production facility in the Czech Republic and several small production firms located throughout Germany. Component supply, tool making and injection molding is centralized at one site (Medi-Globe CardioPlast), while R & D is conducted at several sites in Germany. Several company sales and distribution offices exist in select regions of the world. back